TRIM56 and breast cancer: In fact, both TRIMs’ aberrant overexpression in BC is correlated with poor survival of BC patients, and depletion of these TRIMs leads to reduced cell proliferation, as has been shown for tumor-derived BC cells for TRIM24 [91] and MCF7 cells for TRIM56 [93].